Diego Forero R Email & Phone Number

Casablanca-Settat, Morocco

New York, New York

Bogotá D.C. Area, Colombia

Greater New York City Area

Greater New York City Area

- Responsible for a shadow P & l of U$4.1B sales across EM region.- Establish a new team of 24 people leading the hiring of 15 out of the 19 new team members including 8 senior leaders as direct reports (EPCU Leadership Team)- Sponsor and active participation of a therapeutic prioritization analysis with focus by regions in order to confirm TAs and key products to be supported as well as business development opportunities. - Lead the alignment with partner lines to prioritize and agree on cross-pollinations and product enhancements projects to be implemented in 2014 and beyond to generate revenues by 2018 of U$65M- Guide the launch of a platform that allows colleagues at country level to increase knowledge sharing with more than 400 promotional pieces and 10 training modules for key products.- Identification of key products with performance issues and development of market research to establish root causes of performance and implementation of plan of action to change the trends. (Medrol, Norvasc, Postan)- Lead the Distribution Channel Marketing Capabilities training program development.- Profitability analysis for top 40 brands identifying quick wins (U$3M)

Manhathan

Responsible for US$1,2B sales across LA region.- Prioritize assets and Identify and execute main EP growth strategies for the region - Identify gaps in Regional product/portfolio and design implementation plan to close the gaps - Identify upside opportunities for Tenders business in close collaboration with country tender leads - Work in close collaboration with manufacture, finance, regulatory, and other relevant areas when appropriate to guaranty/restore the normal operation at country level- Identify and help to develop talent- Responsible for the overall EP regional P&L

Dec 2010 - present- Responsible for US$1,4B sales across emerging markets.- Implementation of Gx entry strategy for hospital business launching 50 molecules in more than 50 countries during 2011 - 2012.- Optimization of current assets (Ex-licensing – In licensing) TAs Oncology, Hematology, Inflammation, Anti Infectives- Global Tenders Platform development and implementation in more than 30 countries in EM

- Lead the strategic plan definition for Pfizer established products portfolio by therapeutic area.- Lead the strategic plan definition for Pfizer entering into generics including Biosimilars in Emerging Markets.- Lead the Portfolio GAP project analysis to identify the best molecules to complement current Pfizer established products portfolio and planning launch for generics- Analysis and recommendation of different companies for potential partnering / acquisition.- Lead the established products portfolio categorization/prioritization to optimize lifecycle management and ROI tool development.

United States

President of the Board of Directors ANDI pharmaceutical chamber of the National Business Association of Colombia (ANDI), over 60 National and foreign affiliated companies. Lead the strategy development

Bogota,D.C., Capital District, Colombia

President of the Board of Directors - R & D Pharma companies association. Lead the new vision and strategy development.

Doctor In Medicine, Health

Mba, Management

Marketing Specialist, Marketing

Education record